v3.25.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities    
Net loss $ (20,556,147) $ (28,934,519)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 412,395 337,259
(Gain)/loss on disposal of property and equipment (523) 18,846
Noncash lease expense 257,769 254,695
Credit loss recovery (8,506) (7,367)
Contract modification - related party 280,545
Share-based compensation 4,087
Write-off of demonstration equipment 441,624
Interest expense paid in equity shares 11,798,283
Accrued interest on notes payable 162,713 262,107
Non-cash royalty income (31,991) (13,797)
Amortization of original issue discounts on notes payable 12,500 4,167
Loan origination costs 25,000 5,000
Receipt of SOL from staking (13,138)
Non-cash transaction fees 2,510
Unrealized loss on digital assets 469,860
Loss on exercise of warrant liabilities 4,674,806 15,796,105
Changes in fair value of warrant liability 282,546 10,020,212
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables 3,440,800 1,964,241
Trade receivables - related party 13,386 66,057
Inventory (851,188) (4,126,906)
Contract assets (718,712) (556,032)
Prepaid expenses and other current assets (9,979) 261,559
Other assets 112,030 157,699
Accounts payable (183,748) (1,051,056)
Sales tax payable (53,592) (63,509)
Operating lease liabilities (263,005) (256,271)
Deposits from customers (6,156) (88,285)
Accrued expenses (546,600) 4,743,926
Contract liabilities (112,793) 24,981
Deferred revenue (182,543) (188,930)
Income taxes payable 539,968 (149,142)
Other liabilities 517 32,511
Net cash used in operating activities (891,914) (1,201,817)
Cash Flows from Investing Activities    
Purchase of property and equipment (183,584) (924,428)
Proceeds from sale of property and equipment 523 5,529
Royalties on related party revenues 30,000 10,000
Purchase of marketable securities (100,000)
Investment in MasterpieceVR (100,000)
Net cash used by investing activities (253,061) (1,008,899)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 7,285,840 7,025,841
Payments on revolving line of credit (8,513,678) (6,053,954)
Payments on debt (114,654) (124,912)
Payments on Paycheck Protection Program Loans (10,123)
Proceeds from notes payable 7,000,000 500,000
Proceeds from warrant exercises 5,657,264 1,050,597
Proceeds from offerings 6,000,000
Expenses on offerings (9,473)
Net cash provided by financing activities 17,305,299 2,387,449
Effect of currency translation (724,832) (132,871)
Net increase in cash, cash equivalents, and restricted cash 16,160,324 176,733
Cash, cash equivalents, and restricted cash at beginning of period 6,347,041 5,420,392
Total cash, cash equivalents, and restricted cash 21,782,533 5,464,254
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 20,505,781 4,224,130
Restricted cash 1,276,752 1,240,124
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 150,199 217,639
Cash paid during the period for income taxes, net of refunds 269,680
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay notes payable 19,642,283
Noncash dividends 136 123
Noncash recognition of new leases 364,710 159,086
Series A Warrant Exercises 211,098 21,515,777
Series B Warrant Exercises $ 15,804,854

Source

PDF HTML
ZIP XBRL